Common Contracts

AMENDMENT NO. 1 TO ROYALTY PURCHASE AND SALE AGREEMENT

Royalty Purchase and Sale Agreement • August 9th, 2018 • PDL Biopharma, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Royalty Purchase and Sale Agreement
• Filed
  August 9th, 2018
• Company
  PDL Biopharma, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

AMENDMENT NO. 1 TO ROYALTY PURCHASE AND SALE AGREEMENT AND BILL OF SALE dated as of August 2, 2018 (the “Amendment”) among DEPOMED, INC., a California corporation (“Depomed”), DEPO DR SUB, LLC, a Delaware limited liability company (the “Seller”, and together with Depomed, the “Selling Parties”), and PDL Investment Holdings, LLC, a Delaware limited liability company (as assignee of PDL BIOPHARMA, INC., the “Purchaser”)

AMENDMENT NO. 1 TO ROYALTY PURCHASE AND SALE AGREEMENT AND BILL OF SALE

Royalty Purchase and Sale Agreement • August 8th, 2018 • Depomed Inc • Pharmaceutical preparations • New York

• Contract Type
  Royalty Purchase and Sale Agreement
• Filed
  August 8th, 2018
• Company
  Depomed Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  New York

AMENDMENT NO. 1 TO ROYALTY PURCHASE AND SALE AGREEMENT AND BILL OF SALE dated as of August 2, 2018 (the “Amendment”) among DEPOMED, INC., a California corporation (“Depomed”), DEPO DR SUB, LLC, a Delaware limited liability company (the “Seller”, and together with Depomed, the “Selling Parties”), and PDL INVESTMENT HOLDINGS, LLC, a Delaware limited liability company (as assignee of PDL BIOPHARMA, INC., the “Purchaser”)